Other CR unique proteins which commonly are reported to be associated with the progression and chemoresistance of ovarian carcinomas were Aurora kinase A and B (AURKA and AURKB) [Rsc = 5.6], metastasis associated protein-1 (MTA-1) [Rsc = 5.6], etc. In addition, C-reactive protein (CRP) [Rsc = 4.7] which is commonly elevated in the serum of ovarian cancer patients was also unique to CR tumor population and was not expressed in CN ascites-derived tumor cells (Supplementary Table S5). Here, AURKB is linked to ovarian carcinoma.